These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8203387)

  • 1. Program for procurement of drugs for indigent patients.
    Decane BE; Chapman J
    Am J Hosp Pharm; 1994 Mar; 51(5):669-71. PubMed ID: 8203387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Prescription-Assistance Program for Medically Uninsured Patients With Cancer: Case Study of a Public Hospital Experience in New York State.
    Gao L; Joseph J; Santoro-Levy M; Gotlieb VK; Multz AS
    J Oncol Pract; 2014 Mar; 10(2):104. PubMed ID: 29452556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.
    Gao L; Joseph J; Santoro-Levy M; Multz AS; Gotlieb VK
    Hosp Pharm; 2016 Jul; 51(7):572-6. PubMed ID: 27559190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monetary incentive for pharmacists to control drug costs.
    Herrick JD; Manning SH
    Am J Hosp Pharm; 1985 Jul; 42(7):1527-32. PubMed ID: 4025348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical services and inpatient drug costs in bone marrow transplantation.
    King RS; Wordell CJ; Haupt BA
    Am J Hosp Pharm; 1994 May; 51(10):1339-42. PubMed ID: 8085573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of clinical pharmacy services in a community hospital.
    Williams LE
    Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug-procurement alternatives.
    May BE; Herrick JD
    Am J Hosp Pharm; 1984 Jul; 41(7):1373-8. PubMed ID: 6465153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of implementing and maintaining a hospital-pharmacy-based online literature search system.
    Souney PF; Churchill WW; Kaul AF
    Am J Hosp Pharm; 1985 Nov; 42(11):2496-8. PubMed ID: 4073067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs.
    Peterson JP; Colucci VJ; Schiff SE
    Am J Hosp Pharm; 1991 Sep; 48(9):1962-4. PubMed ID: 1928141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversification strategies for hospital pharmacies.
    Smith JE; Phillips DJ; Meyer GE
    Am J Hosp Pharm; 1984 Sep; 41(9):1788-91. PubMed ID: 6496513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program.
    Weiner S; Dischler J; Horvitz C
    Am J Health Syst Pharm; 2001 Jan; 58(2):146-50. PubMed ID: 11202538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic impact of clinical pharmacists' unsolicited recommendations.
    Torok N; Brown G
    Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A commentary on high-cost drugs.
    de Leon RF
    Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription assistance programs: options for assisting the uninsured and underinsured.
    Turowski RC; Raskay-Bianco MM; Visconti JA
    Hosp Pharm; 1993 Oct; 28(10):948, 951-5, 958-68. PubMed ID: 10129140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology.
    Bond CA; Raehl CL
    Pharmacotherapy; 2008 Jan; 28(1):1-13. PubMed ID: 18154468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.